Literature DB >> 17446305

Giving APCmin tumours a SPARC.

Alex Gregorieff1, Hans Clevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17446305      PMCID： PMC2000252          DOI： 10.1136/gut.2007.122135

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  39 in total

Review 1.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

Authors:  J E Murphy-Ullrich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

Authors:  A D Bradshaw; E H Sage
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice.

Authors:  Cindy A Eads; Andrea E Nickel; Peter W Laird
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

5.  Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

Authors:  Rolf A Brekken; Pauli Puolakkainen; David C Graves; Gail Workman; Sharon R Lubkin; E Helene Sage
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

6.  Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.

Authors:  Karen A Silverman; Revati Koratkar; Linda D Siracusa; Arthur M Buchberg
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

7.  Deficiency of Mbd2 suppresses intestinal tumorigenesis.

Authors:  Owen J Sansom; Jennifer Berger; Stefan M Bishop; Brian Hendrich; Adrian Bird; Alan R Clarke
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

8.  Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice.

Authors:  Catherine B Millar; Jacky Guy; Owen J Sansom; Jim Selfridge; Eilidh MacDougall; Brian Hendrich; Peter D Keightley; Stefan M Bishop; Alan R Clarke; Adrian Bird
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression.

Authors:  Melanie Kucherlapati; Kan Yang; Mari Kuraguchi; Jie Zhao; Maria Lia; Joerg Heyer; Michael F Kane; Kunhua Fan; Robert Russell; Anthony M C Brown; Burkhard Kneitz; Winfried Edelmann; Richard D Kolodner; Martin Lipkin; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

10.  Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice.

Authors:  Owen J Sansom; Fiona C Mansergh; Martin J Evans; Julie A Wilkins; Alan R Clarke
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.